Zephyrnet Logo

Tag: degeneration

FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy

FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic AtrophyTOKYO, Aug. 5, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President...

Genome editing in the treatment of ocular diseases – Experimental & Molecular Medicine

Porteus, M. H. A new class of medicines through DNA editing. N. Engl. J. Med. 380, 947–959 (2019).Article  CAS  PubMed  Google Scholar  Anzalone,...

The Impending Arrival of AI in Eye Care

The Impending Arrival of AI in Eye CareArtificial Intelligence (AI) has been making significant strides in various fields, and now it is set to...

New technology could revolutionize treatment for age-related macular degeneration

Scientists have found a way to use nanotechnology to create a 3D 'scaffold' to grow cells from the retina –paving the way for potential...

CIRM invests $50 million in clinical research, including trial for vision loss

The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, today awarded $50.1 million to fund clinical-stage research...

Sildenafil increases AAV9 transduction after a systemic administration and enhances AAV9-dystrophin therapeutic effect in mdx mice – Gene Therapy

Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet. 2011;12:341–55.Article  CAS  PubMed  ...

Microgravity: the future of R&D?  

<!----> Space: the final frontier…for manufacturing under microgravity conditions. Products made in space could become crucial for R&D in...

Retinopathy: Golgi and Breye join forces

Milan-based biotech incubator Golgi Neurosciences is teaming up with Danish biopharma Breye Therapeutics to develop the P2X7 receptor antagonist programme for the treatment...

July 24 Quick Takes: Kodiak sinks on tarcocimab DME miss

ARTICLE | Product DevelopmentPlus: BMS takes stake in Immatics and updates from Syndax, Incyte, Crescendo, Bavarian Nordic, Horizon, CERSI By BioCentury Staff July 25, 2023 1:25 AM UTC The...

L5 S1 Or Lumbosacral Joint: What Is It And What Should You Be Wary Of?

The L5 S1 joint, or the lumbosacral joint, is a critical joint. It lies between the lumbar segment of the spine and the auricular...

Five Companies Leading the Way in 3D Bioprinting

The field of 3D bioprinting has emerged as a remarkable technological advancement in recent years. This revolutionary technique involves the fabrication of living tissues,...

Santhera licences vamorolone rights to Catalyst Pharmaceuticals

Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals...

Latest Intelligence

spot_img
spot_img